Allergan, Inc Confirmed receipt of unsolicited proposal from Valeant Pharmaceuticals International, Will carefully review VRX offer
- Allergan Board of Directors, in consultation with its financial and legal advisors, will carefully review and consider the Proposal and pursue the course of action that it believes is in the best interests of the Companys stockholders. The Companys stockholders do not need to take any action at this time.